Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sodium Sulfide 1% Gel Ingrown Toenail Safety Shown By Schering-Plough

This article was originally published in The Tan Sheet

Executive Summary

Sodium sulfide 1% gel could be included in the OTC monograph for ingrown toenail relief drugs following a public comment period, FDA tells Schering-Plough HealthCare Products in a May 22 letter.

You may also be interested in...



Ingrown Toenail Treatment Use With Retainer Ring System Proposed By FDA

Sodium sulfide 1% gel is safe and effective for OTC treatment of ingrown toenail pain only when used with a retainer ring system to keep the product at the area of application, FDA says in a 1proposed rule published in the Federal Register Oct. 4

Ingrown Toenail Treatment Use With Retainer Ring System Proposed By FDA

Sodium sulfide 1% gel is safe and effective for OTC treatment of ingrown toenail pain only when used with a retainer ring system to keep the product at the area of application, FDA says in a 1proposed rule published in the Federal Register Oct. 4

Ingrown Toenail Treatment Use With Retainer Ring System Proposed By FDA

Sodium sulfide 1% gel is safe and effective for OTC treatment of ingrown toenail pain only when used with a retainer ring system to keep the product at the area of application, FDA says in a 1proposed rule published in the Federal Register Oct. 4

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091337

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel